Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 7.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IXICO Awarded Development Contract By NHS England Initiative

Wed, 16th Apr 2014 09:54

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they are diagnosed.

In a statement, the brain health company said it will lead the project in partnership with the Health Innovation Network South London, and will build on Assessa, IXICO's digital healthcare platform to support dementia diagnosis, to address post-diagnostic care planning and support.

The project's aim is to harness web and mobile technologies to provide ongoing support and to assist those living with dementia as well as their families, carers and healthcare professionals.

"We are delighted to receive this support from SBRI Healthcare which will help us to extend the potential patient benefit of Assessa? following diagnosis and is central to the widening of our digital healthcare offering. We look forward to working with the Health Innovation Network to improve the care of dementia sufferers," Chief Executive Derek Hill said in a statement.

IXICO shares were Wednesday quoted at 70.00 pence, up 0.7%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
19 Oct 2020 09:38

Ixico FY revenues grow by more than a quarter

(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.

Read more
16 Oct 2020 16:23

Ixico enters deal with NUY Langone Health for drug trial

(Sharecast News) - Data analytics company Ixico has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus, approved by the FDA to prevent organ transplant rejection and for the treatment of a rare and progressive lung disease called lymphangioleiomyomatosis, is also able to slow the progression of disease in people with multiple system atrophy (MSA).

Read more
24 Sep 2020 16:30

Ixico joins Friedreich's Ataxia research consortium

(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).

Read more
24 Sep 2020 16:30

Ixico joins Friedreich's Ataxia research consortium

(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).

Read more
21 Sep 2020 13:35

Ixico selected to support Alzheimer's trial

(Sharecast News) - Data analytics company Ixico has been selected by the Global Alzheimer's Platform Foundation (GAP) to support its planned 'Bio-Hermes' trial.

Read more
24 Aug 2020 09:18

Ixico FY revenues, underlying earnings ahead of forecasts

(Sharecast News) - Data analytics company Ixico said on Monday that it had recorded "stronger-than-anticipated" second-half revenues and underlying earnings despite Covid-19.

Read more
24 Jun 2020 09:41

Ixico sees only 'modest' impact on trading from Covid-19

(Sharecast News) - Data analytics company Ixico said on Wednesday that Covid-19 had only had a "modest" impact on trading and stated it expects to maintain double-digit revenue growth in 2021.

Read more
20 Apr 2020 08:50

Ixico in 'robust' position to handle short-term Covid-19 headwinds

(Sharecast News) - Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.

Read more
14 Apr 2020 09:32

Ixico inks ?10.5m contract, trading impacted by Covid-19 in 'multiple ways'

(Sharecast News) - Neuroscience data analytics firm Ixico has inked a £10.5m contract for a late-phase open-label study into Huntington's disease, but warned that the Covid-19 pandemic had affected it in "multiple ways".

Read more
3 Feb 2020 14:05

Ixico joins Alzheimer's disease research initiative

(Sharecast News) - Artificial intelligence data analytics company Ixico announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI) on Monday, with two of its scientists to join the ADNI-Private Partner Scientific Board (PPSB).

Read more
23 Jan 2020 16:10

Director dealings: Ixico CEO ups stake

(Sharecast News) - Ixico revealed on Thursday that chief executive Giulio Cerroni had purchased 24,800 ordinary shares in the British clinical research firm.

Read more
23 Dec 2019 15:04

Ixico announces extensions to two studies

(Sharecast News) - Data analytics company Ixico announced a £1.8m extension to a phase 3 study in Huntington's Disease on Monday, which it had previously announced in September 2018.

Read more
28 Oct 2019 13:15

Ixico secures three new contracts, appoints chief business officer

(Sharecast News) - AI data analytics company Ixico said on Monday that it had secured three new contracts and appointed a chief business officer.

Read more
15 Oct 2019 15:33

Ixico flags better-than-expected performance for full-year

(Sharecast News) - Artificial intelligence data analytics company Ixico updated the market on its trading for the year ended 30 September on Tuesday, saying it expected its first full year of positive EBITDA since listing.

Read more
15 Oct 2019 12:30

IXICO Predicts Maiden Positive Ebitda In Financial 2019

IXICO Predicts Maiden Positive Ebitda In Financial 2019

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.